Entera Bio (NASDAQ:ENTX) Stock Rating Reaffirmed by HC Wainwright
Entera Bio (NASDAQ:ENTX – Get Free Report)‘s stock had its “buy” rating reiterated by equities research analysts at HC Wainwright in a report issued on Wednesday, Benzinga reports. They currently have a $10.00 price objective on the stock. HC Wainwright’s price target would indicate a potential upside of 378.47% from the company’s previous close. Entera […]
More Stories
Ipswich Investment Management Co. Inc. Sells 150 Shares of General Electric (NYSE:GE)
Ipswich Investment Management Co. Inc. reduced its stake in shares of General Electric (NYSE:GE – Free Report) by 1.6% in...
Archer Investment Corp Increases Stock Position in Automatic Data Processing, Inc. (NASDAQ:ADP)
Archer Investment Corp grew its position in shares of Automatic Data Processing, Inc. (NASDAQ:ADP – Free Report) by 5.4% during...
1776 Wealth LLC Sells 198 Shares of Salesforce, Inc. (NYSE:CRM)
1776 Wealth LLC cut its holdings in shares of Salesforce, Inc. (NYSE:CRM – Free Report) by 2.9% in the 3rd...
Philip Morris International Inc. (NYSE:PM) Stake Lessened by Cutler Investment Counsel LLC
Cutler Investment Counsel LLC decreased its holdings in shares of Philip Morris International Inc. (NYSE:PM – Free Report) by 9.6%...
The Walt Disney Company (NYSE:DIS) Shares Purchased by Natixis Advisors LLC
Natixis Advisors LLC boosted its stake in shares of The Walt Disney Company (NYSE:DIS – Free Report) by 3.1% in...
AbbVie (NYSE:ABBV) Now Covered by Analysts at Wolfe Research
Wolfe Research initiated coverage on shares of AbbVie (NYSE:ABBV – Free Report) in a report published on Friday, Marketbeat.com reports....